Report Description

Global Red Biotechnology Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028.  This can be attributed to factors such as growing demand for genetic engineering, development of new medicines for the treatment of life-threatening diseases and the increased production of precision medicine.

Red Biotechnology focuses on the therapeutic or diagnostic use of living cells, and their components, to develop novel medical treatments and cures for diseases and health issues. It includes the creation of a wide range of goods, including medicines, diagnostic instruments, vaccines, gene treatments, and other products for the treatment and prevention of different diseases.

The growing demand for precision medicine is enhancing the market opportunities and increasing demand for the global red biotechnology market.

Growing Demand for Genetic Engineering

Increase in demand for genetic engineering has been observed due to increase in biologic drugs. According to IQVIA Institute data, biologic drugs represented 2 percent of all United States prescriptions, but comprises of 37% net drug spending. The growing use of genetic engineering such as recombinant DNA technology in creating genetically modified organisms such as therapeutic antibodies is propelling the growth of red biotechnology market across the globe. The technologies such as gene editing such as CRISPR-based genetic editing, is also becoming much prevalent in the market and thereby is supporting the market growth by expanding the applications of red biotechnology in genetic engineering. Additionally red biotechnology is found to have application in production of spinal discs, artificial bones, skin and cartilages through tissue engineering techniques.


Download Free Sample Report
Development of new medicines for the treatment of Life-threatening diseases

Red biotechnology has found application in fields such as in gene therapy, clinical trials, diagnostics, and research.  Also, the growing number of clinical trials for the development of drugs along with rise in acceptance and demand for biosimilars affect the growth of red biotechnology in the recent scenario. The expansion of the biopharmaceutical sector of red biotechnology market is expected to grow with increasing clinical trials in medicine production. For instance, In July 2022, Replay-a genomic medicine producing startup invested USD55 million in a seed funding round to develop and transform genomic medicine through an interlinking stage for developing various genotype genomic research to discover new disease targets and enhance and improve the disease diagnosis & treatment.

Increased production of precision medicine

The growing prevalence of chronic diseases across the world is creating a rising demand for precision medicine. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and has recorded around 9.6 million deaths globally. With the increasing number of cancer patients worldwide, the growth of red biotechnology market is also expanding as it is utilized for diagnosing reason for these diseases by using genetic testing and sequencing techniques, etc. and thereby has found many lucrative opportunities in diagnosis, drug development and treatment for diseases such as cancer and is thereby expected to bolster market growth in the forecast period. Along with this, red biotechnology is utilized in combined vaccine production such as Hepatitis B, merged with polio vaccine and DPT merged with Hepatitis A and this all-together is of great importance to support the market growth in the forecast period.

Recent Development

In June 2022, Bluebird Bio has developed a new gene therapy and is being evaluated by the United States Food Drug and Administration regarding the treatment of (CALD) cerebral adrenoleukodystrophy (a genetic condition that damages the membrane myelin sheath of the brain) in patients under adolescent age.

Market Segmentation

Global Red Biotechnology Market is segmented based on the product type, application, end-user, region and competitive landscape. Based on product type, the market is segmented into diagnostic reagents, human vaccines, blood products, gene recombinant drugs and others. Based on application, the market is segmented into biopharmaceutical production, gene therapy, genetic testing, pharmacogenomics, drug discovery and others. Based on end-user, the market is segmented into pharmaceutical and biotechnology companies, CMO & CRO, research institute and others.

Market Players

Pfizer, Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche, Ltd., Bruker, Merck KGaA, Celgene Corporation, Amgen, Inc., etc., are some of the major players operating in the Global Red Biotechnology Market.

Attribute

Details

Base Year

2022

Historical Years

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Product type

Application

End-user

Regional Scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait

Key Companies Profiled

Pfizer, Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche, Ltd., Bruker, Merck KGaA, Celgene Corporation, Amgen, Inc.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Global Red Biotechnology Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Red Biotechnology Market, By Product Type:
    • Diagnostic Reagents
    • Human Vaccines
    • Blood Products
    • Gene Recombinant drugs
    • Others
  • Red Biotechnology Market, By Application:
    • Biopharmaceutical Production
    • Gene Therapy
    • Genetic Testing
    • Pharmacogenomics
    • Drug Discovery
    • Others
  • Red Biotechnology Market, By End-User:
    • Pharmaceutical and Biotechnology companies
    • CMO & CRO
    • Research Institute
    • Others
  • Red Biotechnology Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Red Biotechnology Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Red Biotechnology Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered.

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Red Biotechnology Market Outlook.

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs and Others)

5.2.2.    By Application (Biopharmaceutical Production, Gene Therapy, Genetic Testing, Pharmacogenomics, Drug Discovery, and Others)

5.2.3.    By End-User (Pharmaceutical and Biotechnology companies, CMO & CRO, Research Institute and Others)

5.2.4.    By Company (2022)

5.2.5.    By Region

5.3.  Product Market Map

6.    Asia-Pacific Red Biotechnology Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    Product Type

6.2.2.    End-User

6.2.3.    By Country

6.3.  Asia-Pacific: Country Analysis

6.3.1.    China Red Biotechnology Market Outlook.

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           Product Type

6.3.1.2.2.           End-User

6.3.2.    India Red Biotechnology Market Outlook.

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           Product Type

6.3.2.2.2.           End-User

6.3.3.    South Korea Red Biotechnology Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           Product Type

6.3.3.2.2.           End-User

6.3.4.    Japan Red Biotechnology Market Outlook

6.3.4.1.        Market Size & Forecast

6.3.4.1.1.           By Value

6.3.4.2.        Market Share & Forecast

6.3.4.2.1.           Product Type

6.3.4.2.2.           End-User  

6.3.5.    Australia Red Biotechnology Market Outlook

6.3.5.1.        Market Size & Forecast

6.3.5.1.1.           By Value

6.3.5.2.        Market Share & Forecast

6.3.5.2.1.           Product Type

6.3.5.2.2.           End-User

7.    Europe Red Biotechnology Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    Product Type

7.2.2.    End-User

7.2.3.    By Country

7.3.  Europe: Country Analysis

7.3.1.    France Red Biotechnology Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           Product Type

7.3.1.2.2.           End-User

7.3.2.    Germany Red Biotechnology Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           Product Type

7.3.2.2.2.           End-User

7.3.3.    United Kingdom Red Biotechnology Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           Product Type

7.3.3.2.2.           End-User

7.3.4.    Italy Red Biotechnology Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           Product Type

7.3.4.2.2.           End-User

7.3.5.    Spain Red Biotechnology Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           Product Type

7.3.5.2.2.           End-User

8.    North America Red Biotechnology Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    Product Type

8.2.2.    End-User

8.2.3.    By Country

8.3.  North America: Country Analysis

8.3.1.    United States Red Biotechnology Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           Product Type

8.3.1.2.2.           End-User

8.3.2.    Mexico Red Biotechnology Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           Product Type

8.3.2.2.2.           End-User

8.3.3.    Canada Red Biotechnology Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           Product Type

8.3.3.2.2.           End-User

9.    South America Red Biotechnology Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    Product Type

9.2.2.    End-User

9.2.3.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Red Biotechnology Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           Product Type

9.3.1.2.2.           End-User

9.3.2.    Argentina Red Biotechnology Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           Product Type

9.3.2.2.2.           End-User

9.3.3.    Colombia Red Biotechnology Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           Product Type

9.3.3.2.2.           End-User

10. Middle East and Africa Red Biotechnology Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. Product Type

10.2.2. End-User

10.2.3. By Country

10.3.             MEA: Country Analysis

10.3.1. South Africa Red Biotechnology Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         Product Type

10.3.1.2.2.         End-User

10.3.2. Saudi Arabia Red Biotechnology Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         Product Type

10.3.2.2.2.         End-User

10.3.3. UAE Red Biotechnology Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         Product Type

10.3.3.2.2.         End-User

10.3.4. Kuwait Red Biotechnology Market Outlook

10.3.4.1.     Market Size & Forecast

10.3.4.1.1.         By Value

10.3.4.2.     Market Share & Forecast

10.3.4.2.1.         Product Type

10.3.4.2.2.         End-User

11. Market Dynamics

11.1.             Drivers

11.2.             Challenges

12. Market Trends & Developments

12.1.             Recent Developments

12.2.             Mergers & Acquisitions

12.3.             Product Developments

13. Competitive Landscape

13.1.             Business Overview

13.2.             Company Snapshot

13.3.             Products & Services

13.4.             Financials (In case of listed companies)

13.5.             Recent Developments

13.6.             SWOT Analysis

13.6.1.  Pfizer, Inc.

13.6.2.  Takeda Pharmaceutical Company Limited

13.6.3.  Gilead Sciences

13.6.4.  Regeneron Pharmaceuticals, Inc.

13.6.5.  F. Hoffmann-La Roche, Ltd.

13.6.6.  Bruker

13.6.7.  Merck KGaA

13.6.8.  Celgene Corporation

13.6.9.  Amgen, Inc.

13.6.10.   Biogen, Inc.,

14. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The rising prevalence of cancer and other chronic diseases and growing advancement in artificial intelligence are factors driving the growth of the Global Red Biotechnology Market in the forecast years, 2024-2028.

down-arrow

Pfizer, Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche, Ltd., Bruker, Merck KGaA, Celgene Corporation, Amgen, Inc. etc. are some of the companies leading the Global Red Biotechnology Market.

down-arrow

North America dominates the Global Red Biotechnology Market due to the growing research and development in cancer diagnosis and increased advancement in artificial advancement, creating medicine and antibiotic from live cells to better human health.

down-arrow

The high cost and hectic numerous trials requiring longer time are some of the key factors hampering the growth of Global Red Biotechnology Market in the forecast period.

profile

Sakshi Bajaal

Business Consultant
Press Release

Red Biotechnology Market to be dominated by the Biopharmaceutical Production Segment by 2028

May, 2023

Rising product development and genetic engineering for treatment of chronic diseases are expected to drive Global Red Biotechnology Market in the forecast period, 2024-2028.